Statins for primary prevention of cardiovascular (CV) events
Metadata[+] Show full item record
Bottom line: This study supports the growing body of evidence for statins in primary prevention of CV events in white men, but provides insufficient evidence for whether this benefit extends to women or ethnically diverse populations.Review and summary of: Yusuf S, Bosch J, Dagenais G, et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016; 374(21):2021-2031.
Evidence-based practice 20, no. 5 (2017): E1